{"title": "Healthcare and Pharmaceutical News & Insights - Zuellig Pharma", "author": null, "url": "https://www.zuelligpharma.com/news-insights", "hostname": "zuelligpharma.com", "description": "Explore the latest Healthcare and Pharmaceutical News by Zuellig Pharma - the largest healthcare services groups in Asia.", "sitename": "Zuellig Pharma", "date": "2023-08-01", "cleaned_text": "Healthcare and Pharmaceutical News & Insights All Animal Health Clinical Reach Clients Consumer Health Healthcare Providers Insurance & Corporations Medical Devices and Diagnostics Pharmaceutical Companies [](https://www.zuelligpharma.com/b/zuellig-pharma-singapore-and-gsk-establish-vaccine-distribution-hub-to-improve-asia-s-access-to-vaccines) Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia's Access to Vaccines Zuellig Pharma, one of the largest healthcare services groups in Asia, today announced that it has entered into an agreement with global biopharma company, GSK, to help set up its first vaccine distribution hub in the region. 01 August 2023 [](https://www.zuelligpharma.com/b/interpharma-investments-limited-appoints-alfonso-chito-zulueta-as-non-executive-chairman) Interpharma Investments Limited appoints Alfonso \"Chito\" Zulueta as Non-Executive Chairman Interpharma Investments Limited, holding company of leading healthcare services provider Zuellig Pharma, today announced the appointment of Mr. Alfonso \"Chito\" Zulueta as Non-Executive Chairman of its Board. Effective 1 June 2023, Mr. Zulueta succeeds Mr. Patrick Davies, who stepped down after serving as Non-Executive Chairman for four years. 05 May 2023 [](https://www.zuelligpharma.com/b/zuellig-pharma-recognised-with-a-score-of-a-on-cdp-supplier-engagement-in-industry-first) Zuellig Pharma recognised with a score of \"A-\" on CDP supplier engagement in industry first Recognition further affirms company's decarbonisation efforts, having been awarded the CDP Climate Change score of \"B\" for 2022. 27 April 2023 [](https://www.zuelligpharma.com/b/covid-19-vaccines-clinical-trial-environment) COVID-19 Vaccines Clinical Trial Environment The World Health Organization officially declared the coronavirus outbreak a pandemic in March 2020. By June 2021, 170 vaccine candidates for COVID-19 had been developed. Of these, 90 were being tested in human clinical trials, 30% had reached Phase 3 and selected vaccines had been authorised for emergency use. There are at least 440 clinical trials with mRNA candidates and at least 140 for viral vectors. 15 December 2022 [](https://www.zuelligpharma.com/b/zuellig-pharma-brings-logistics-expertise-to-support-the-thai-government-in-distribution-of-one-million-doses-of-covid-19-vaccine-moderna-donated-by-the-us-government-for-thai-people) Zuellig Pharma brings logistics expertise to support the Thai government in distribution of one million doses of COVID -19 vaccine Moderna donated by the US government for Thai people Zuellig Pharma announced its commitment to support the Thai Government, through the Department of Disease Control, Ministry of Public Health. 01 September 2022 [](https://www.zuelligpharma.com/b/zp-therapeutics-ready-to-deliver-the-first-shipment-of-covid-19-vaccine-moderna-to-increase-vaccine-access-in-thailand) ZP Therapeutics ready to deliver the first shipment of COVID-19 vaccine Moderna to increase vaccine access in Thailand ZP Therapeutics is ready to deliver the first shipment of 560,000 doses of COVID-19 Vaccine Moderna to the Government Pharmaceutical Organisation (GPO) for distribution to the Private Hospital Association in an effort to increase access to alternative vaccines for the people of Thailand. 10 November 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-and-gw-pharmaceuticals-sign-a-partnership-agreement-in-taiwan) Zuellig Pharma and GW Pharmaceuticals sign a partnership agreement in Taiwan Zuellig Pharma announced a new partnership with GW Pharmaceuticals (GW) to support access to cannabis-based medicines in Taiwan. GW, part of Jazz Pharmaceuticals plc, is a world leader in discovering, developing, and delivering regulatory approved cannabis-based medicines. 04 November 2021 [](https://www.zuelligpharma.com/b/updates-on-the-first-shipment-of-covid-19-vaccine-moderna-to-thailand) Updates on the first shipment of COVID-19 vaccine Moderna to Thailand ZP Therapeutics, a division of Zuellig Pharma and the official partner of Moderna in Thailand, confirms that the first shipment of 560,000 doses of COVID-19 Vaccine Moderna will arrive in Thailand within 5 November 2021, based on the latest schedule provided by Moderna. 29 October 2021 [](https://www.zuelligpharma.com/b/department-of-disease-control-appoints-zuellig-pharma-to-handle-20-million-doses-pfizer-biontech-covid-19-vaccines-in-thailand) Department of disease control appoints Zuellig Pharma to handle 20 million doses Pfizer-BioNTech COVID-19 vaccines in Thailand Zuellig Pharma has been appointed by the Department of Disease Control to handle and distribute another 20 million doses of the Pfizer-BioNTech COVID-19 vaccines in Thailand. 08 October 2021 [](https://www.zuelligpharma.com/b/making-good-mental-health-a-reality) Making good mental health a reality Technology like smartphones, laptops and smartwatches have blurred the lines between work and personal time even before the COVID-19 pandemic hit us almost two years ago. 05 October 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-receives-ecovadis-platinum-sustainability-rating-for-the-year-2021) Zuellig Pharma receives EcoVadis Platinum Sustainability rating for the year 2021 The award is the highest accolade to be awarded to a company for its sustainability efforts and positions Zuellig Pharma in the top 1% of all assessed companies worldwide. 04 October 2021 [](https://www.zuelligpharma.com/b/chulabhorn-royal-academy-signs-agreement-with-zuellig-pharma-to-purchase-eight-million-doses-of-covid-19-vaccine-moderna) Chulabhorn Royal Academy signs agreement with Zuellig Pharma to purchase eight million doses of COVID-19 vaccine Moderna The Chulabhorn Royal Academy (CRA) announced an official agreement with ZP Therapeutics, a division of Zuellig Pharma on the supply and distribution of eight million doses of the COVID-19 Vaccine Moderna in Thailand. 24 September 2021 [](https://www.zuelligpharma.com/b/thailand-s-food-and-drug-administration-expands-authorisation-of-covid-19-vaccine-moderna-for-use-in-adolescents-12-to-17-years-old) Thailand's food and drug administration expands authorisation of COVID -19 vaccine Moderna for use in adolescents 12 to 17 years old ZP Therapeutics, a division of Zuellig Pharma today announced that Thailand Food and Drug Administration (FDA) has expanded the authorisation of the COVID-19 Vaccine Moderna for use in adolescents aged 12 to 17 years old. 23 September 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-wins-four-awards-at-the-asia-corporate-excellence-sustainability-awards-2021) Zuellig Pharma wins four awards at the Asia corporate excellence & sustainability awards 2021 Zuellig Pharma, a leading healthcare services provider in Asia, has been presented with four leadership and sustainability awards, in both individual and enterprise categories, at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. 03 September 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-thailand-collaborates-with-the-department-of-disease-control-ddc-to-provide-nationwide-distribution-services-of-1-5million-doses-of-pfizer-biontech-covid-19-mrna-vaccines) Zuellig Pharma Thailand collaborates with the department of disease control (ddc) to provide nationwide distribution services of 1.5million doses of pfizer-biontech COVID -19 mrna vaccines Zuellig Pharma is committed to leveraging our experience, expertise and our best in class cold chain solutions for distribution of vaccines, pharmaceutical and medical products to provide access to COVID-19 vaccines to the people in Thailand. 30 July 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-thailand-supports-chulalongkorn-university-to-develop-southeast-asia-s-first-covid-19-mrna-vaccine) Zuellig Pharma Thailand supports Chulalongkorn University first COVID -19 mrna vaccine Zuellig Pharma is working with Chulalongkorn University to develop ChulaCov19, Southeast Asia's first COVID-19 mRNA vaccine. As part of the ChulaCov19 mRNA vaccine programme, Zuellig Pharma managed the clinical trials, which included storing and distributing the vaccines to clinical sites. 29 July 2021 [](https://www.zuelligpharma.com/b/government-pharmaceutical-organisation-confirms-purchase-of-five-million-doses-of-covid-19-vaccine-moderna) Government pharmaceutical organisation confirms purchase of five million doses of COVID -19 vaccine Moderna ZP Therapeutics, a division of Zuellig Pharma, today announced an official agreement with the Government Pharmaceutical Organisation (GPO) to supply and distribute five million doses of the COVID-19 Vaccine Moderna in Thailand from the fourth quarter of 2021. 23 July 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-corporation-welcomes-arrival-of-covid-19-vaccine-moderna-doses-in-the-philippines) Zuellig Pharma corporation welcomes arrival of COVID-19 vaccine Moderna doses in the Philippines Zuellig Pharma Corporation was authorised by Moderna as the emergency use authorisation holder (through its commercialisation division, ZP Therapeutics) for its COVID-19 vaccine in the Philippines. 29 June 2021 [](https://www.zuelligpharma.com/b/international-finance-corporation-and-mitsui-to-invest-c-us-60-million-in-singapore-based-micare-health-technologies) International finance corporation and Mitsui to invest c.US$60 million in Singapore-based Micare health technologies The strategic investment will be used to fund MiCare's expansion in key Southeast Asian markets including Indonesia and Vietnam as well as to set up a new regional headquarters in Singapore. 27 May 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-s-employee-survey-uncovers-key-insights-to-reduce-vaccination-hesitancy-across-asia) Zuellig Pharma's employee survey uncovers key insights to reduce vaccination hesitancy across Asia Zuellig Pharma marked the week from 24 to 30 April 2021 with a series of events to engage employees on the topic of immunisation. This included a company-wide survey to understand if employees had concerns about vaccination and what these concerns stem from. 14 May 2021 [](https://www.zuelligpharma.com/b/over-1-750-attendees-joined-zuellig-pharma-s-inaugural-immunisation-matters-virtual-summit) Over 1,750 attendees joined Zuellig Pharma's inaugural immunisation matters virtual summit Held in conjunction with the WHO's World Immunisation Week 2021, the landmark event saw experts across various fields coming together to lead exciting discussions on innovative ways to roll out vaccines in Asia 30 April 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-partners-with-moderna-to-supply-moderna-s-covid-19-vaccine-in-asia) Zuellig Pharma partners with Moderna vaccine in Asia Zuellig Pharma and Moderna, Inc. announced a new partnership with Zuellig Pharma's division, ZP Therapeutics, to supply the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan. 28 April 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-clinches-ecovadis-gold-medal-2021-for-sustainability) Zuellig Zuellig Pharma, a leading healthcare services provider in Asia has been awarded the Gold Medal 2021 from sustainability ratings specialist EcoVadis. 15 April 2021 [](https://www.zuelligpharma.com/b/access-to-healthcare) Access to healthcare Zuellig Pharma plays a vital role as a connector, driving collaboration across the healthcare ecosystem so that more parties can be involved to make healthcare more accessible to everyone. 07 April 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-scoops-two-wins-at-asia-pacific-bioprocessing-excellence-awards-2021) Zuellig Pharma scoops awards 2021 Zuellig Pharma today announced that it has scooped two titles at the Asia-Pacific Bioprocessing Excellence Awards 2021. The company clinched awards for 'Best Warehousing & Distribution' and 'Best Last Mile Implementation' for a second year running. 18 March 2021 [](https://www.zuelligpharma.com/b/assurance-of-supply-chain-integrity-for-the-covid-19-vaccine-1) Assurance of supply chain integrity for the COVID-19 vaccine The COVID-19 pandemic defence has entered a new phase since the start of 2021 with vaccine supplies slowly beginning to arrive in countries across the globe, as part of the internationally funded COVAX programme or through direct purchases by country governments from manufacturers. 18 March 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-launches-ezvax-a-vaccine-management-solution-for-safe-vaccine-distribution-and-administration) Zuellig Pharma launches ezvax, a vaccine management solution for safe vaccine distribution and administration Zuellig Pharma today announced the launch of eZVax, a vaccine management solution that enables governments and private clients to manage all aspects of vaccine distribution and administration. 11 March 2021 [](https://www.zuelligpharma.com/b/how-we-champion-supplier-sustainability-at-zuellig-pharma) How we champion supplier sustainability at Zuellig Pharma Companies have started to think critically about how to integrate Sustainability throughout their supply chain and are focusing on Sustainable Procurement. 20 January 2021 [](https://www.zuelligpharma.com/b/zuellig-pharma-achieves-hr-asia-s-singapore-s-best-companies-to-work-for-in-asia-award) Zuellig Pharma achieves HR Asia's Singapore's best companies to work for in Asia award In a year marked by a pandemic and continued global uncertainty, 32 companies across Singapore have been named among HR Asia's Best Companies to Work for in Asia. 28 December 2020 [](https://www.zuelligpharma.com/b/ensuring-safe-vaccines-with-eztracker) Ensuring safe vaccines with eztracker To help governments, pharmaceutical companies and healthcare providers combat the trade in fake medicines, Zuellig Pharma launched eZTracker in the region earlier this year. 09 December 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-collaborates-with-hsbc-to-transform-collections-and-payments-process-with-omni-collect-online-solution) Zuellig Pharma collaborates with HSBC to transform collections and payments process with omni collect online solution The solution delivers Zuellig Pharma Malaysia a bespoke end-to-end product that has streamlined their collections and payments process. 25 November 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-expands-cold-storage-warehouse-capacity-across-key-markets-in-asia-in-preparation-for-covid-19-vaccine) Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID -19 vaccine Zuellig Pharma announced that it will significantly expand its cold storage warehouse capacity in key regional markets over the next 12 months. 19 November 2020 [](https://www.zuelligpharma.com/b/face-to-face-doctor-consultations-decrease-in-the-philippines-during-pandemic-new-survey-reveals) Face-to-face doctor consultations decrease in the philippines during pandemic, new survey reveals Filipino doctors are conducting much fewer consultations since the COVID-19 health crisis in March this year, according to a recent survey conducted by a team of researchers from Zuellig Pharma. 10 October 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-begins-distribution-of-korea-s-first-covid-19-treatment) Zuellig Pharma begins distribution of Korea's first COVID-19 treatment Zuellig Pharma has signed a partnership agreement with Celltrion, a Korean leading biopharmaceutical group to distribute Regkirona (Regdanvimab) for COVID-19 patients in Korea. 02 October 2020 [](https://www.zuelligpharma.com/b/placing-safety-at-the-heart-of-corporate-culture) Placing safety at the heart of corporate culture COVID-19 has underscored the critical role that safety plays in businesses. As Asia's leading healthcare services provider, over 350,000 hospitals, clinics and medical centres rely on Zuellig Pharma to deliver healthcare products. 28 September 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-launches-virtual-care-application) Zuellig pharma launches virtual care application Zuellig Pharma has launched eZConsult, a virtual care mobile app to address the growing need for teleconsultation amidst lockdowns and restricted movement during the global COVID-19 pandemic. 06 August 2020 [](https://www.zuelligpharma.com/b/celebrating-international-women-s-day-part-2) Celebrating international women's day: part 2 This International Women's Day, we interview three outstanding female colleagues from our Commercial Solutions team. 03 August 2020 [](https://www.zuelligpharma.com/b/standing-zpunited-in-extraordinary-times) Standing #zpunited in extraordinary times Zuellig Pharma in response to the impact on the healthcare landscape, have witnessed their teams across all 13 markets and business units come together in exceptional ways to make healthcare accessible to the communities they serve. 07 July 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-appoints-john-graham-as-new-ceo) Zuellig Pharma appoints John Graham as new CEO Zuellig Pharma announces the appointment of John Graham as its new CEO. John will run the US$13 billion business and lead the team across our 13 markets in Asia. 01 July 2020 [](https://www.zuelligpharma.com/b/how-supply-chains-will-evolve-in-the-wake-of-covid-19) How supply chains will evolve in the wake of COVID-19 The COVID-19 has had far-reaching effects on global supply chains. Supply chains all over the world have been put to the test as countries and businesses battle to effectively manage disruptions caused by the pandemic. 26 June 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-partners-with-luye-pharma-to-distribute-and-market-seroquel-and-seroquel-xr-in-hong-kong) Zuellig Pharma partners with Luye Pharma to distribute and Seroquel XR\u00ae in Hong Kong Zuellig Pharma enters a partnership agreement with Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. 01 June 2020 [](https://www.zuelligpharma.com/b/celebrating-international-women-s-day-part-1) Celebrating international women's day: part 1 This International Women's Day, we interview three outstanding female colleagues from our Distribution & Client Services team. Hear from Natalie Guo, Ngo Hong Mai and Imelda Leslie V. Rillon as they share about their role models and advice for women in healthcare. 03 May 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-thailand-supports-ministry-of-public-health-in-battling-pandemic-through-provision-of-delivery-and-distribution-services-for-covid-19-treatment-medication-at-no-cost) Zuellig Pharma Thailand supports ministry of public health in battling pandemic through provision of delivery and distribution services for COVID-19 treatment medication at no cost The COVID-19 outbreak has seen more than 1,800 infected patients in nearly all provinces within Thailand. This aims to support the country in its fight against the virus. 02 April 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-joins-poseidon-network-as-main-distribution-partner-in-asia-pacific) Zuellig Pharma joins Poseidon network as main distribution partner in Asia Pacific Formed in 2018, the Poseidon network is a best-in-class community of progressive pharmaceutical companies and logistics providers that has come together with the collective goal of reforming the pharmaceutical logistics process 12 March 2020 [](https://www.zuelligpharma.com/b/celebrating-international-women-s-day-part-3) Celebrating international women's day: part 3 This International Women's Day, we interview three outstanding female colleagues from our CareConnect team. Hear from Lily Lan, Karen Goh and Sirena Loh as they share about what motivates them, their female role models and words of wisdom for women in the healthcare industry. 10 March 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-acquires-alliance-pharma-cambodge-in-cambodia-to-strengthen-indochina-presence) Zuellig Pharma acquires Alliance Pharma (Cambodge) in Cambodia to strengthen Indochina presence Zuellig Pharma, a leading healthcare services provider in Asia, has announced that it has acquired a controlling stake in Alliance Pharma (Cambodge), a leading healthcare distributor of Cambodia. 03 March 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-launches-blockchain-based-eztracker-in-thailand-to-help-consumers-verify-authorised-aesthetics-products-in-seconds) Zuellig Pharma launches blockchain-based eztracker in Thailand to help consumers verify authorised aesthetics products in seconds Zuellig Pharma has announced the launch of eZTracker in Thailand and partnered with global pharmaceutical company, Galderma (Thailand) Ltd to help consumers identify unauthorized aesthetics products 15 February 2020 [](https://www.zuelligpharma.com/b/apl-inaugurates-largest-national-distribution-centre-in-indonesia) APL inaugurates largest national distribution centre in Indonesia As part of their commitment to increase healthcare access in Indonesia, PT Anugerah Pharmindo Lestari (APL) officially introduced its new state-of-the-art National Distribution Centre (NDC), located in West Java, Indonesia, on 3 February 2020. 14 February 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-awarded-ecovadis-silver-medal-2020-for-sustainability) Zuellig pharma awarded ecovadis silver medal 2020 for sustainability Leading healthcare services provider Zuellig Pharma has received a Silver medal from sustainability rating specialist EcoVadis for its commitment to driving sustainability within its business. 22 January 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-provides-the-ezcooler-solution-and-training-to-improve-vaccination-outcomes-in-vietnam) Zuellig Pharma provides the eZCooler solution and training to improve vaccination outcomes in Vietnam As part of the partnership with the National Institute for Control of Vaccines and Biologicals (NICVB) and the National Institute of Hygiene and Epidemiology (NIHE) to improve access to vaccination in Vietnam, Zuellig Pharma Vietnam organised an event to handover US$600,000 worth of the eZCooler solution on 20 December 2019. 21 January 2020 [](https://www.zuelligpharma.com/b/philippine-academy-of-family-physicians-collaborates-with-ezconsult-for-family-and-community-engagement-through-telehealth-service-facets-programme) Philippine Academy of Family Physicians collaborates with eZConsult for family and community engagement through Telehealth service (Facets) programme The Philippine Academy of Family Physicians (PAFP) will collaborate with telemedicine app eZConsult as the digital platform for its remote consultation initiative dubbed Family and Community Engagement through Telehealth Service (FACETS). 15 January 2020 [](https://www.zuelligpharma.com/b/micare-group-partners-with-pfizer-and-tokio-marine-life-to-launch-iembrace-a-patient-assistance-programme-for-metastatic-breast-cancer-mbc-in-malaysia) MiCare group partners with Pfizer and Tokio Marine Life to launch iEMBRACE, a patient assistance programme for metastatic breast cancer (MBC) in Malaysia Through the collaboration and its common goal of increasing access to innovative medicines and healthcare services at an affordable cost, mBC patients are able to live fulfilling and productive lives despite their ailment. 07 January 2020 [](https://www.zuelligpharma.com/b/zuellig-pharma-enters-into-strategic-partnership-with-eli-lilly-and-company-in-malaysia-and-thailand) Zuellig Pharma enters into strategic partnership with Eli Lilly and company in Malaysia and Thailand Zuellig Pharma, a leading healthcare service provider in Asia, is pleased to announce two new strategic partnerships with Eli Lilly and Company (Lilly) to market, sell and distribute the healthcare manufacturer's existing and new products in Malaysia and Thailand. 22 October 2019 [](https://www.zuelligpharma.com/b/molnlycke-and-zuellig-pharma-strengthen-partnership-for-advanced-wound-care-solutions-in-south-east-asia) M\u00f6lnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia The commercialisation of Granulox and Granudacyn in South-East Asia was previously managed by SastoMed's exclusive strategic partner, Zuellig Pharma, one of Asia's largest healthcare services provider. 05 Healthtech start-up Klinify, to support the development of technology that empowers doctors to modernise their practices and simplify workflows. 30 May 2019 [](https://www.zuelligpharma.com/b/zuellig-pharma-nicvb-and-nihe-announce-project-to-expand-access-to-vaccines-in-vietnam-through-the-use-of-innovative-ezcooler-solution) Zuellig Pharma, NICVB and Nihe announce project to expand access to vaccines in Vietnam through the use of innovative ezcooler solution Under the agreement, Zuellig Pharma will contribute hundreds of the innovative eZCooler solution, a temperature-controlled packaging technology to maintain product quality during transportation. 18 April 2019 [](https://www.zuelligpharma.com/b/why-healthcare-needs-to-break-down-the-great-wall-of-data) Why healthcare needs to break down the great wall of data Many organisations struggle with consolidating and translating the wealth of data they have into actionable insights because the data sits in segregated silos. These silos stem from the need to comply with strict data privacy policies and laws, resulting in various clinical, financial and operational data being housed separately. 11 April 2019 [](https://www.zuelligpharma.com/b/our-people-1) Our People Celebrating International Women's Day with Byun Soo Yoon, Head of Logistics Zuellig Pharma Korea 27 March 2019 [](https://www.zuelligpharma.com/b/our-people) Our People Celebrating International Women's Day with Pucknalin Bulakul, Chief Operating Officer Zuellig Pharma Thailand 27 March 2019 [](https://www.zuelligpharma.com/b/our-people-2) Our People Celebrating International Women's Day with Tan Yan Ann, Chief Executive Zuellig Pharma Singapore 19 March 2019 [](https://www.zuelligpharma.com/b/our-people-3) Our People Celebrating International Women's Day with our VP Procurement Victoria Folbigg 12 March 2019 [](https://www.zuelligpharma.com/b/keeping-it-real-how-we-fightthefakes) Keeping it real - how we #fightthefakes It's Fight the Fakes Week, an international campaign where organisations, governments and individuals unite to raise awareness about the dangers of fake medicines. 03 December 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-named-information-visionary-at-the-singapore-idc-digital-transformation-awards-2018) Zuellig Pharma named 'information visionary' at the Singapore IDC digital transformation awards 2018 Out of 600 entries across Asia Pacific, the healthcare services company was named the top spot alongside United Overseas Bank Limited (UOB), a leading bank in Asia. 31 October 2018 [](https://www.zuelligpharma.com/b/mdi-works-with-dsap-to-support-healthcare-professionals) MDI works with DSAP to support healthcare professionals MDI has signed an MOA with the Drugstores Association of the Philippines (DSAP) to host their website and launch a product catalog page to DSAP members exclusively. 08 October 2018 [](https://www.zuelligpharma.com/b/apl-wins-distribution-contract-with-bioderma-pt-dermanesia-group-of-naos-company-) APL wins distribution contract with Bioderma (pt. Dermanesia, group of naos company) APL has been appointed the distributor for leading dermocosmetic company Bioderma Laboratoire Dermatologique in Indonesia. 24 September 2018 [](https://www.zuelligpharma.com/b/warming-up-to-myanmar-and-cambodia) Warming up to Myanmar and Cambodia In the past decade, Myanmar and Cambodia have seen immense GDP growth and corresponding increases in healthcare expenditure per capita, ushering in a new era for healthcare policy-making that brings a renewed focus to improving accessibility. 27 August 2018 [](https://www.zuelligpharma.com/b/integrating-the-hardware-with-heart-ware-) Integrating the hardware with \"heart-ware\" By creating a synergistic relationship between technology and talent, this can drive employee engagement and help our employees to live, work and play better. 20 August 2018 [](https://www.zuelligpharma.com/b/tan-tock-seng-hospital-the-wound-healing-society-singapore-and-zuellig-pharma-team-up-to-advance-wound-care-expertise-in-singapore) Tan Tock Seng hospital, the wound healing society Singapore and Zuellig Pharma team up to advance wound care expertise in Singapore The ICW certifies wound care professionals and their hospitals and clinics as wound management trainers and centres in their respective countries. Over 30,000 healthcare professionals have been certified by the ICW across Europe. 08 August 2018 [](https://www.zuelligpharma.com/b/mdi-inks-deal-with-mylan-philippines) MDI inks deal with Mylan Philippines A global healthcare company, Mylan is the second-largest generic and speciality pharmaceutical company in the world with a diverse portfolio spanning more than 7,500 products. 08 August 2018 [](https://www.zuelligpharma.com/b/fragmentation-is-weakening-healthcare-digitisation-can-help-fix-it-) Fragmentation is weakening healthcare. Digitisation can help fix it. We have invested in Klinify, a cloud-based clinic management solution that facilitates the crucial consolidation of medical records, and Docquity, a secure peer-to-peer learning network that allows doctors to discuss individual cases, browse scientific journals and participate in educational activities. 03 August 2018 [](https://www.zuelligpharma.com/b/beyond-distribution-apl-to-sell-and-promote-products-for-eli-lilly-and-company-in-indonesia) Beyond distribution, APL to sell and promote products for Eli Lilly and company in Indonesia Under this partnership, APL will be looking to launch Lilly's new portfolio in the areas of diabetes, oncology and immunology in the future. 01 August 2018 [](https://www.zuelligpharma.com/b/mdi-reaffirms-partnership-with-lundbeck) MDI reaffirms partnership with Lundbeck A global pharmaceutical company, Lundbeck is committed to improving the quality of life of individuals living with psychiatric and neurological disorders. 23 July 2018 [](https://www.zuelligpharma.com/b/digitising-last-mile-delivery) Digitising last-mile delivery As an enterprise whose core business lies in distribution, digitising our last-mile delivery is key to addressing some of our biggest challenges; high delivery volume and cost, process optimisation and slow sales recognition. 17 July 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-recognised-for-outstanding-workplace-culture) Zuellig Pharma recognised for outstanding workplace culture Building an environment that nurtures individuals in their careers and personal lives is key to Zuellig Pharma's people-first approach. 13 July 2018 [](https://www.zuelligpharma.com/b/will-blockchain-change-the-pharmaceutical-supply-chain-) Will blockchain change the pharmaceutical supply chain? At Zuellig Pharma, we operate the most comprehensive supply and cold chain network in the healthcare industry across the region. 26 June 2018 [](https://www.zuelligpharma.com/b/maximising-value-for-quality-healthcare) Maximising value for quality healthcare 2018 marks the midway point in Zuellig Pharma's strategic transformation journey. Over the past few years, the business has strengthened its operating fundamentals while driving new innovations and operating efficiencies. 12 June 2018 [](https://www.zuelligpharma.com/b/moving-from-sick-care-to-healthcare-with-predictive-analytics) Moving from sick-care to healthcare with predictive analytics Insights to how Zuellig Pharma leverages predictive analytics to achieve the right intervention at the right time. 07 June 2018 [](https://www.zuelligpharma.com/b/ensuring-the-highest-quality-standards-throughout-the-distribution-process) Ensuring the highest quality standards throughout the distribution process Picking the right partner for quality assurance 21 May 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-invests-in-docquity-an-online-learning-network-for-doctors) Zuellig Pharma invests in Docquity, an online learning network for doctors Leading healthcare services group buys into second tech company. The Singapore-based HealthTech startup aims to connect medical professionals globally over a secure digital platform. 17 May 2018 [](https://www.zuelligpharma.com/b/apl-recognised-as-one-of-the-best-companies-to-work-for-in-indonesia) APL recognised as one of the best companies to work for in Indonesia Asia's most authoritative publication for senior HR professionals - investigates best practices and the inner workings of companies, to understand what distinguishes them as employers. 08 May 2018 [](https://www.zuelligpharma.com/b/all-aboard-the-cold-chain) All aboard the cold chain The global cold chain market is poised to grow around 7.8% over the next decade to reach approximately US$339.15 billion by 2025. One of the biggest driving forces behind this growth is the rising demand for pharmaceuticals that require temperature-control infrastructure and technologies. 25 April 2018 [](https://www.zuelligpharma.com/b/taiho-pharma-singapore-enters-into-partnership-with-zuellig-pharma-malaysia) Taiho pharma singapore enters into partnership with Zuellig Pharma Malaysia Zuellig Pharma Malaysia has entered into a distribution agreement with Taiho Pharma Singapore for their latest product, the TS-ONE OD Tablet. 09 April 2018 [](https://www.zuelligpharma.com/b/the-zuellig-group-incorporated-zgi-has-acquired-temasek-s-investment-in-interpharma-investments-limited-zuellig-pharma-) The Zuellig Group incorporated (ZGI) has acquired Temasek's investment in Interpharma Investments Limited (Zuellig Pharma) The relationship with Temasek has proven beneficial to both parties, and both ZGI and the board of Zuellig Pharma wish to record their appreciation of the contribution of the Temasek directors to the work and deliberations of the board. 04 April 2018 [](https://www.zuelligpharma.com/b/hr-as-change-agent) HR as change agent Supporting a major business transformation and helping to launch a new innovation centre are just two of the items on Fauzi Wahab's agenda. 28 March 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-hopes-to-put-wings-on-korean-drugs) Zuellig Pharma hopes to put wings on Korean drugs The Korean unit of leading Asian health care provider Zuellig Pharma's goal is to facilitate the global launch of more pharmaceuticals developed by domestic drug makers, its top executive said on March 20. 22 March 2018 [](https://www.zuelligpharma.com/b/bayer-malaysia-and-zuellig-pharma-go-digital-to-keep-cancer-patients-on-track) Bayer Malaysia and Zuellig Pharma go digital to keep cancer patients on track In conjunction with World Cancer Day on 4 February 2018, Bayer Malaysia partnered with our CareConnect team to launch an integrated Patient Assistance Program (PAP) through a web app called BayPAP. 20 March 2018 [](https://www.zuelligpharma.com/b/plugging-healthcare-gaps-in-asia) Plugging healthcare gaps in Asia One of the largest forces shaping the healthcare landscape today is the move towards Universal Health Coverage (UHC), driven by the WHO. 19 March 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-and-fresenius-medical-care-enters-strategic-partnership-in-myanmar-and-cambodia) Zuellig Pharma and Fresenius Medical care enters strategic partnership in Myanmar and Cambodia Zuellig Pharma is appointed by Fresenius Medical Care, the world's largest provider of dialysis products and services, as its exclusive logistics service provider in Myanmar. 05 March 2018 [](https://www.zuelligpharma.com/b/the-rise-of-clinical-trials) The rise of clinical trials By 2020, the global market for clinical trials is expected to reach US$57 billion, an 80% increase from 2015. The majority of this demand is driven by a single region - Asia. 31 January 2018 [](https://www.zuelligpharma.com/b/battling-today-s-lifestyle-illnesses) Battling today's lifestyle illnesses The World Health Organisation (WHO) confirmed that 70% of deaths (40 million people) were caused by non-communicable diseases (NCDs) in 2017, and that it is a real and growing threat in Asia. 23 January 2018 [](https://www.zuelligpharma.com/b/real-time-information-on-products-and-performance) Real time information on products and performance Zuellig Pharma recently completed a company-wide transition to the SAP HANA platform, marking a significant milestone in their reporting systems. 04 January 2018 [](https://www.zuelligpharma.com/b/zuellig-pharma-partners-with-the-vietnamese-government-for-cold-chain-storage-management-safeguarding-the-quality-of-vaccines) Zuellig Pharma partners with the Vietnamese government for cold chain storage management, safeguarding the quality of vaccines MoU was signed between Zuellig Pharma Vietnam Ltd, the National Centre for Control of Vaccines and Biologicals, and the National Institute of Hygiene and Epidemiology. 18 December 2017 [](https://www.zuelligpharma.com/b/improving-healthcare-in-asia) Improving healthcare in Asia Since the 1800s, philanthropy has played a prominent role in the development of the healthcare sector in Singapore, a point Minister for Health Gan Kim Yong highlighted in his speech at the Credit Suisse Philanthropists Forum 2017. 17 November 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-inks-deal-with-lead-chemical) ZUELLIG PHARMA INKS DEAL WITH LEAD CHEMICAL Zuellig Pharma has established a new strategic partnership with Lead Chemical to support the company as it ramps up international distribution of Loxoprofen patches around the region. 07 November 2017 [](https://www.zuelligpharma.com/b/supporting-the-demand-for-investigator-initiated-trials) Supporting the demand for investigator-initiated trials Investigator-initiated trials (IITs) are clinical studies initiated and managed by independent investigators, often researchers from academic institutions, who test existing licensed drugs for different therapeutic indicators. 10 August 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-leads-the-discussion-on-the-future-of-specialty-medicine-and-healthcare) Zuellig pharma leads the discussion on the future of specialty medicine and healthcare Zuellig Pharma Korea recently supported a Medical World News forum that focused on \"The present and future of specialty medicine and healthcare\". The event aimed to address the concerns of the fast growing specialty medicine market and its impact on the industry. 07 August 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-contributes-to-the-ascent-challenge-by-action4diabetics) Zuellig Pharma contributes to the ascent challenge by Action4Diabetics Asian countries contribute to more than 60% of the world's diabetic population. This has serious economic consequences, as diabetes is a chronic disease that requires long-term treatments and medical care. 03 August 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-partners-with-novo-nordisk-in-malaysia-singapore-brunei) Zuellig Pharma partners with Novo Nordisk in Malaysia, Singapore, Brunei Zuellig Pharma recently signed an agreement with Novo Nordisk to distribute the company's products on behalf of its affiliate covering the markets in Malaysia, Singapore and Brunei. 31 July 2017 [](https://www.zuelligpharma.com/b/spotlight-on-myanmar) Spotlight on Myanmar Myanmar's healthcare industry has significant growth potential, but succeeding in the market requires an approach that navigates the country's underdeveloped healthcare infrastructure, talent gap and affordability challenges. 27 July 2017 [](https://www.zuelligpharma.com/b/pharma-transport-modal-shifts-the-air-to-sea-switch) Pharma transport modal shifts: the air to sea switch As pharmaceutical companies cope with the rising cost of operations, many are shifting to sea-freight as a main mode of transport from manufacturing centers to markets for patient consumption. 18 July 2017 [](https://www.zuelligpharma.com/b/interview-with-apl-management-trainee-annisa-ayudhita-chandra) Interview a 6-month assignment as a supply chain & engineering project executive. 10 July 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-extends-partnership-with-novartis-in-brunei) Zuellig Pharma extends partnership with Novartis in Brunei Building on a decade of partnership, Zuellig Pharma Brunei and Novartis have entered into a new collaboration that will see Zuellig Pharma distribute for Novartis and Sandoz, a sub division of Novartis. 05 July 2017 [](https://www.zuelligpharma.com/b/facing-healthcare-s-financial-reality) Facing healthcare's financial reality Asia faces a crisis of financial sustainability in the healthcare sector. ASEAN alone spent more than US$63 billion on healthcare in 2013 and the region's ageing population and increasing rates of chronic disease means that this figure is likely to double in the next decade. 03 July 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-vietnam-supports-nguyen-van-huong-scholarship-program) Zuellig Pharma Vietnam supports Nguyen Van Huong Scholarship program Enabling the development of young medical professionals is an important part of Zuellig Pharma's business in Vietnam and this year the company is celebrating its 15th year of support for the Nguyen Van Huong Scholarship. 28 June 2017 [](https://www.zuelligpharma.com/b/new-secondary-repackaging-area-opened-in-malaysia) New secondary repackaging area opened in Malaysia Zuellig Pharma has established a new strategic partnership with Sumitomo Dainippon Pharma that will accelerate the growth of Meronem, a broad spectrum, injectable carbapenem antibiotic, in Vietnam, Thailand, Singapore, Philippines, Malaysia and Hong Kong. 26 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-tw-q2-2017) Taiwan - Views from the Region Taiwan's growth momentum continued in Q1 2017, with the economy expanding 2.6% year on year, according to advance estimates released in April. The better than expected showing gives the government room to raise its 2017 full-year GDP growth target to above 2% 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q2-2017) Hong Kong - Views from the Region Hong Kong will have a new Chief Executive from July 1 with the elevation of Carrie Lam, Chief Secretary for Administration, to the top post in the city's government. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-sg-q2-2017) Singapore - Views from the Region The country's economy grew by 2.5% year on year in Q1 2017, according to advance estimates. Despite a decline in output from the biomedical engineering, transport engineering and general manufacturing clusters, the electronics and precision engineering clusters saw strong expansion, contributing to growth. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ko-q2-2017) Korea - Views from the Region The economy grew at a faster pace in Q1 2017 than three months earlier, due to increased construction investment and exports, according to central bank data. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q2-2017) Malaysia - Views from the Region The latest International Monetary Fund (IMF) annual consultation report on Malaysia stated that despite low commodity prices and volatility in financial markets, the economy has remained resilient due to its diversified production and export base, strong balance sheet, flexible exchange rate, and responsive macroeconomic policies. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-mya-q2-2017) Myanmar - Views from the Region Q1 2017 maintained the upward trend seen at the end of 2016, with healthy growth in GDP driven in part by continued foreign investment. As a result, some banks have increased their full-year GDP growth forecasts for 2017. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-thai-q2-2017) Thailand - Views from the Region Thailand's practice of compulsory licensing, which is allowed by the World Trade Organisation, enabling generics of certain drugs regarded as essential to be produced to lessen costs, is a particular issue for US pharmaceutical companies. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q2-2017) Philippines - Views from the Region The Philippines posted GDP growth of 6.8% in 2016, up from 5.9% in 2015 and a three-year high. The country has one of the fastest growing economies in Asia-Pacific. 19 June 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q2-2017) Indonesia - Views from the Region Indonesia's economy achieved robust results in Q1 2017, expanding by 5.01% compared with the same period last year. 19 June 2017 [](https://www.zuelligpharma.com/b/new-secondary-repackaging-area-opened-in-malaysia-1) New secondary repackaging area opened in Malaysia Zuellig Pharma Malaysia has recently opened a new, best in-class Secondary Repackaging Area for both consumer health and pharmaceutical products. 09 June 2017 [](https://www.zuelligpharma.com/b/stepping-up-medical-device-and-diagnostic-capabilities-in-taiwan) Stepping up medical device and diagnostic capabilities in Taiwan Zuellig Pharma Taiwan has recently established a new strategic partnership with Cardinal Health Medical Products, supporting the company as it accelerates its growth plans in the region. 08 June 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-cambodia-appointed-vice-chairman-of-the-cambodia-healthcare-committee) Zuellig Pharma Cambodia appointed Vice-Chairman of the Cambodia Healthcare committee Proud to announce that Zuellig Pharma Cambodia was elected the Vice-Chairman of the Cambodia Healthcare committee last month. 05 June 2017 [](https://www.zuelligpharma.com/b/customizing-solutions-for-medical-device-clients-in-malaysia) Customizing solutions for medical device clients in Malaysia Improving inventory management for medical device clients has been high on the agenda for our Zuellig Pharma Malaysia team, who went live with a new SAP-based medical device kitting solution earlier this month. 26 May invests in Singapore-based healthtech startup Klinify, helping to drive the development of technology that allows doctors to go digital without interrupting their work processes. 23 May 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-thailand-steps-up-reporting-capabilities) Zuellig Pharma Thailand steps up reporting capabilities Zuellig Pharma Thailand has implemented a next generation reporting system that will allow the company to provide clients with real time information on product portfolios and performance. 16 May 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-invests-in-health-benefit-consultants) Zuellig Pharma invests in health benefit consultants Zuellig Pharma has today announced it has purchased a significant interest in Health Benefit Consultants Co., Ltd. (HBC) through its Malaysian subsidiary - MiCare Sdn Bhd. 09 May 2017 [](https://www.zuelligpharma.com/b/calling-for-collaboration-innovation-to-tackle-diabetes) Calling for collaboration, innovation to tackle diabetes The world is facing a healthcare crisis. More than 415 million people suffer from diabetes and scientists believe that this will reach 700 million by 2025 if current trends continue. 08 May 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-and-pacific-aa-group-sign-pledge-with-ministry-of-health-and-sports-to-launch-scholarship-for-nurses-in-myanmar) Zuellig Pharma and Pacific AA Group sign pledge with ministry of health and sports to launch scholarship for nurses in Myanmar Zuellig Pharma and Pacific-AA Group are gearing up to launch a new scholarship that will support the education and development of nurses in Myanmar. 05 May 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-myanmar-and-pacific-aa-group-launch-strategic-partnership) Zuellig Pharma Myanmar and Pacific - AA Group launch strategic partnership The two companies officially launched their partnership yesterday at an event in Yangon, which was attended by Myanmar Union Minister of Health and Sports Dr. Myint Htwe, Yangon Division Chief Minister, U Phyo Min Thein as well as healthcare companies, practitioners and other partners from across the healthcare community. 02 May 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-korea-participates-in-volunteer-baking-activity) Zuellig Pharma Korea participates in volunteer baking activity Zuellig Pharma Korea teamed up with the Red Cross last month to bake and deliver bread to people in the local community. 20 April 2017 [](https://www.zuelligpharma.com/b/celebrating-micare-s-11th-anniversary) Celebrating Micare's 11th Anniversary MiCare, Zuellig Pharma's subsidiary in Malaysia, celebrated its 11th anniversary last month. MiCare was established in 2006 and has grown to become one of the largest partners for Payors in Malaysia, supporting almost 6,000 companies and 2 million members. 10 April 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-malaysia-signs-distribution-agreement-with-taiho-pharma-singapore) Zuellig Pharma Malaysia Signs Pharma Singapore Pte. Ltd. has appointed Pharma Malaysia as the sole distributor for TAS-102 (trifluridine and tipiracil, marketed under brand name \"Lonsurf\u00ae\" in Japan, USA and Europe) - a colorectal cancer treatment product in Malaysia. 07 April 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-to-invest-over-50-million-in-singapore-based-innovation-centre) Zuellig Pharma to Invest Over $50 Million Innovation Centre Zuellig Pharma has officially launched Zuellig Health Solutions (ZHS), a new Singapore-based innovation centre, established with the support of the Singapore Economic Development Board (EDB). 04 April 2017 [](https://www.zuelligpharma.com/b/stepping-up-supply-chain-capabilities) Stepping Up Supply Chain Capabilities Changing technology across the pharmaceutical industry makes capability building more important than ever before - a fact that was underlined by experts speaking at last month's Biologistics Asia conference in Singapore. 28 March 2017 [](https://www.zuelligpharma.com/b/fm-global-presents-17-awards-to-zuellig-pharma) FM Global Presents 17 Awards To Zuellig Pharma Zuellig Pharma's distribution operations have been recognized by FM Global for their commitment to property loss prevention and risk management. 24 March 2017 [](https://www.zuelligpharma.com/b/insights-from-zuellig-pharma-s-advanced-management-program) Insights From Zuellig Pharma's Advanced Management Program Zuellig Pharma's newly launched Advanced Management Program aims to further develop the skills and competencies of its current and future leaders. 08 March 2017 [](https://www.zuelligpharma.com/b/driving-digital-transformation-improving-health-outcomes) Driving Digital Transformation, Improving Health Outcomes The index, which assesses overall progress on digital transformation within countries and across industries, acknowledges that the healthcare industry \"is behind\" when compared to leading sectors, but states that investment in a number of key areas is being made. 01 March 2017 [](https://www.zuelligpharma.com/b/ethica-partnership-with-zuellig-pharma-gets-underway) Ethica Partnership with Zuellig Pharma gets Underway In January, APL started its sole distributorship for Ethica products. Ethica is part of a joint venture between Fresenius Kabi and Soho Global Health. 23 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-kh-q2-2017) Cambodia - Views from the Region In March, the World Bank forecast a slight dip in economic growth by 2019 due to rising inflation and a slowdown in the expansion of garment manufacturing. This means that while Cambodia's GDP growth is still projected to top Vietnam and Thailand's in 2019, it might align more closely with Burma and Laos. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-mya-q1-2017) Myanmar - Views from the Region In April 2016, Myanmar's newly elected government came to power while major floods in July and August significantly affected Myanmar's agricultural yield, However, economic growth remained impressive, with an estimated 7% over full-year 2016, according to the World Bank. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q1-2017) Hong Kong - Views from the Region Hong Kong continues its rollercoaster ride, with the economy appearing weak, particularly in the retail sector. The impact on the healthcare industry is seen through the decline of the OTC sector but there are encouraging signs on the specialty front so the sector overall is still showing highsingle digit growth. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-kh-q1-2017) Cambodia - Views from the Region The World Bank Group's annual ease-of-doing business report praised Cambodia, ranked at 131 out of 190 economies, for narrowing the gap with leading countries in terms of best practices. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q1-2017) Indonesia - Views from the Region In Q4 2016, Indonesia's economy expanded at its slowest pace since Q1. GDP contracted by 1.8% quarter on quarter as private consumption stalled; and there was a further reduction in fiscal spending due to a legally binding deficit ceiling. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q1-2017) Philippines - Views from the Region The Philippine economy, as measured by real gross domestic product (GDP), grew by 7% in the first three quarters of 2016, among the fastest in Asia and globally. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-thai-q1-2017) Thaliand - Views from the Region It does signify that 2017 may be a year without major upheavals and therefore favourable for economic growth. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q1-2017) Malaysia - Views from the Region Malaysia's GDP grew a healthy 4.3% in Q3 2016, and the Malaysian Institute of Economic Research (MIER) and World Bank estimate GDP growth to be 4.2% for full-year 2016. For 2017, the Institute forecasts GDP to edge up moderately, registering growth of between 4%-4.5% while the World Bank projects 4.3%. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ko-q1-2017) Korea - Views from the Region Bank of Korea, the country's central bank, revised down its growth outlook from 2.8% to 2.5%, citing sluggish domestic demand. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-sg-q1-2017) Singapore - Views From the Region Based on advance estimates from the Ministry of Trade and Industry, Singapore's GDP grew by 1.8% in 2016. While Q4 2016 saw a strong improvement in manufacturing and services, overall annual growth for the year was the nation's weakest since 2009. 22 February 2017 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-tw-q1-2017) Taiwan - Views From the Region Taiwan's economy grew 2.03% year on year in Q3 2016, compared with 1.13% growth in Q2, as domestic consumption firmed and global demand for the island's electronics exports rebounded. 22 February 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-and-vifor-consumer-health-sign-regional-licensing-deal) Zuellig Pharma and Vifor Consumer Health Sign Regional Deal Zuellig Pharma and Vifor Consumer Health, a Galenica Group company based in Switzerland, have recently stepped up their relationship, signing a regional licensing deal that will see Zuellig Pharma take responsibility for the import, distribution, marketing and sale of Perskindol across Asia. 16 February 2017 [](https://www.zuelligpharma.com/b/deputy-minister-of-health-visits-zuellig-pharma-malaysia) Deputy Minister of Health Visits Zuellig Pharma Malaysia Minister of Health YB Dato' Seri Dr. Hilmi Haji Yahya and a delegation from Clinical Research Malaysia this week visited Zuellig Pharma's distribution facilities to learn more about the company and the state-of-the art services it provides. 14 February 2017 [](https://www.zuelligpharma.com/b/recognition-for-assistance-with-serialization-system-roll-out-in-korea) Recognition for Assistance with Serialization System Roll Out in Korea Zuellig Pharma Korea Logistics Director, SooYoon Byun has received an appreciation plaque from the Health Insurance Review & Assessment Service (HIRA) in recognition of her contribution to the introduction and implementation of the country's serialisation system. 10 February 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-cambodia-expands-distribution-centre-opens-new-commercial-branch) Zuellig Pharma Cambodia Expands Distribution Centre, Opens New Commercial Branch Zuellig Pharma Cambodia is continuing to strengthen its investment in Cambodia, opening a second warehouse within its Phnom Penh distribution centre as well as a new commercial branch. 03 February 2017 [](https://www.zuelligpharma.com/b/apl-receives-best-distributor-award-from-mandiri-inhealth) APL Receives Best Distributor Award from Mandiri Inhealth APL's excellent service standards have been recognised by PT. Mandiri InHealth - one of the largest insurance companies in Indonesia - who presented the team with their 'best distributor award' last December. 01 February 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-appoints-myanmar-general-manager) Zuellig General Manager Frederik Meerhoff as General Manager Zuellig Pharma Myanmar, a new role that will help the company expand its footprint in this exciting growth market. Mr Meerhoff is located in Yangon and began the role in January this year. 19 January 2017 [](https://www.zuelligpharma.com/b/zuellig-pharma-launches-advanced-management-program) Zuellig Pharma Launches Advanced Management Program Zuellig Pharma's newly launched Advanced Management Program aims to further develop the skills and competencies of its current and future leaders. 16 January 2017 [](https://www.zuelligpharma.com/b/building-supply-chain-resilience) Building Supply Chain Resilience Mitigating supply chain risk has always been top-of-mind for pharma logistics providers but rapid regulatory change is making risk management more critical than ever before. 28 December 2016 [](https://www.zuelligpharma.com/b/sharing-the-christmas-spirit-in-the-philippines) Sharing the Christmas Spirit in the Philippines Zuellig Pharma Philippines distributed 1,875 Hatid Saya bags to people across the country this month aspart of the team's annual Christmas community outreach initiative. 22 December 2016 [](https://www.zuelligpharma.com/b/scaling-up-innovation-through-collaboration) Scaling-up Innovation Through Collaboration Leaders at this month's Galen Growth Asia HealthTech CEO Summit emphasised the importance of collaboration in fast-tracking innovation and improving the efficiency and reach of the healthcare sector. 21 December 2016 [](https://www.zuelligpharma.com/b/developing-future-leaders) Developing Future Leaders Twenty-two Zuellig Pharma employees have recently become the newest members of the company's Young Talent Program (YTP) which aims to develop a pipeline of future Zuellig Pharma leaders and accelerate the careers of high potential employees. 13 December 2016 [](https://www.zuelligpharma.com/b/stepping-up-investment-in-temperature-management) Stepping Up Investment in Temperature Management Strategic investment in infrastructure is essential for pharma logistics providers to survive. This is according to the Staying Ahead in Temperature-Controlled Cargo Handling panel recently held at the Asian Logistics and Maritime Conference in Hong Kong. 11 December 2016 [](https://www.zuelligpharma.com/b/debating-asia-s-changing-healthcare-landscape) Debating Asia's Changing Healthcare Landscape Shifting demographics, digitisation and evolving local policy are changing the face of the healthcare industry today 05 December 2016 [](https://www.zuelligpharma.com/b/zuellig-pharma-to-launch-ketotop-in-malaysia-and-singapore) Zuellig Pharma to Launch Ketotop and Singapore Zuellig Pharma is partnering with Handok, an established Korean healthcare company, to relaunch its topical analgesic medicine, Ketotop, in Singapore and Malaysia. 30 November 2016 [](https://www.zuelligpharma.com/b/stepping-up-our-call-center-capabilities-in-thailand) Stepping up our Call Center Capabilities in Thailand Zuellig Pharma Thailand has upgraded its call center facilities in order to better meet the needs of its clients, customers and other partners across the country. 22 November 2016 [](https://www.zuelligpharma.com/b/breaking-down-barriers-to-immunization) Breaking Down Barriers to Immunization Immunization has been making headlines in recent months following outbreaks of preventable diseases in multiple countries across the region. 14 November 2016 [](https://www.zuelligpharma.com/b/zuellig-pharma-collaborates-with-taiko-on-cleverin-in-taiwan) Zuellig Pharma Collaborates with Taiko on Cleverin\u00ae in Taiwan Building on many years of partnership, Zuellig Pharma Taiwan and Taiko Pharmaceutical Limited have kicked off a new collaboration that will see Zuellig Pharma distribute and promote Cleverin\u00ae in Taiwan. 09 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q3-2016) Hong Kong - Views from the Region There have been mixed signs in the Hong Kong economy recently. Housing transactions have showed a surprising upturn in both the primary market, supported by favourable mortgage plans and the secondary market. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q3-2016) Indonesia - Views from the Region The domestic economy achieved growth of 5.18% year on year in Q2 2016, up from 4.91% year on year in the previous quarter. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ko-q3-2016) Korea - Views from the Region Economic growth was greatly assisted by the construction industry as output increased 12.4% on-year, with manufacturing output also up by 2.2% year on year. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q3-2016) Malaysia - Views from the Region Malaysia's economy decelerated for the fifth consecutive quarter. In Q2 2016, GDP growth slid to 4%, from 4.2% in the previous quarter. GDP growth was 5.3% for the first half of last year. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q3-2016) Philippines - Views from the Region The Philippine economy grew 7% in Q2 2016, up from 6.8% in the first quarter. The country still had the fastest-growing economy among the major emerging economies in Asia Q2, followed by China (6.7%), Vietnam (5.6%), Indonesia (5.2%) and Malaysia (4%). 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-sg-q3-2016) Singapore - Views from the Region Singapore's real GDP grew by 2.1% in Q2 2016 on a year-on-year basis, while the Consumer Price Index declined by 0.9% year on year. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-tw-q3-2016) Taiwan - Views from the Region Taiwan's economy grew by a better- than-expected 0.7% year on year in Q2 2016, according to official data released in August. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-th-q3-2016) Thailand - Views from the Region Zuellig Pharma offers its deepest condolences to the Thai people on the passing of His Majesty King Bhumibol Adulyadej. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-vi-q3-2016) Vietnam - Views from the Region In Q2 2016, GDP growth was reported at 5.55%, 0.2% lower than the same period last year. GDP growth during the first six months of the year reached 5.52%, down from 6.32% last year. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-kh-q2-2016) Cambodia - Views from the Region The report acknowledged that the country has now embraced the \"factory Asia\" model of economic growth, focusing on manufacturing labor-intensive products for export as labor costs keep increasing in China and neighbouring countries. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-sg-q2-2016) Singapore - Views from the Region According to the Ministry of Trade and Industry, the Singapore economy grew by 1.8% in Q1 2016 on a year-on-year basis. April marked the eighteenth month of negative inflation for the nation, with discretionary spending among consumers slowing alongside the economy. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-tw-q2-2016) Taiwan - Views from the Region The Directorate General of Budget, Accounting and Statistics, a government body, revised down its GDP growth forecast for 2016 from February's projection of 1.47% to 1.06%, citing sluggish global recovery. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ko-q2-2016) Korea - Views from the Region The Organization for Economic Cooperation and Development (OECD) cut its 2016 growth forecast for the South Korean economy from 3.1% to 2.7%, citing sluggish global trade and a slowdown in China. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q2-2016) Malaysia - Views from the Region The Malaysian economy grew 4.2% in Q1 2016, its lowest growth since the financial crisis of 2008. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-th-q2-2016) Thailand - Views from the Region Pharmaceutical Research and Manufacturers of America (PhRMA) has requested in its 2016 Special 301 Report that Thailand remains on the Priority Watch List, amid concerns about intellectual property and market access barriers. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q2-2016) Philippines - Views from the Region The Philippines posted GDP growth of 6.9% in Q1 2016, setting a pace among the fastest in Asia and beating even China's 6.7% growth. The increase marked the Philippines' highest quarterly GDP gain since Q2 2013. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q2-2016) Indonesia - Views from the Region An encouraging macro-economic picture has emerged for the country, with the US dollar exchange rate stabilizing in the past 12 months at an average of US1:13,400 rupiah and a cut in the basic lending from 7.5% to 6.5% by the central bank bringing in cheaper borrowing. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-vi-q2-2016) Vietnam - Views from the Region Under Vietnam's five-year socio-economic development plan covering 2016-2020, the government expects to achieve 6.5%-7% real GDP growth, with 2016 targeted to grow at 6.7%. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q2-2016) Hong Kong - Views from the Region Along with Mainland China, Hong Kong faces adjustment to a different economic climate as growth slows. Both the Financial Secretary and the richest man in Hong Kong have declared that the city is likely to go through a downturn. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-kh-q1-2016) Cambodia - Views from the Region Cambodia ended 2015 with 7.1% real GDP growth, driven by solid performances in the garment sector, tourism and construction. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-vi-q1-2016) Vietnam - Views from the Region In January 2016, the 12th National Party Congress took place, resulting in the election of a new Central Committee, consisting of 180 permanent and 20 alternate members. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q1-2016) Indonesia - Views from the Region On the supply side, all main sectors of the economy (agriculture, manufacturing, mining, wholesale and retail) recorded weaker growth in 2015 than in 2014. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q1-2016) Philippines - Views from the Region GDP grew at 6% in Q3 2015, the fastest to date in 2015, bringing growth in the first three quarters to 5.6%, down from 6% in the same period in 2014. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-th-q1-2016) Thailand - Views from the Region New deputy premier for economic affairs Dr. Somkid Jatusripitak has set up 12 working groups comprising Thai CEOs and top government officials. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q1-2016) Malaysia - Views from the Region Malaysia's Consumer Sentiment Index sank to a fresh low in Q4 2015, dipping to 63.8 points from 70.2 points in Q3 2015. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q1-2016) Hong Kong - Views from the Region The Pharmacy & Poisons Board of Hong Kong is also introducing stricter quality controls after joining the Pharmaceutical Inspection Co-operation Scheme (PIC/S) at the start of 2016. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-kh-q4-2015) Cambodia - Views from the Region The World Bank's real GDP growth forecasts for 2015 were revised downward, from 7.1% to 6.9%, in October, as exports and tourism faced increased competition from low-wage competitors, such as Myanmar. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-id-q4-2015) Indonesia - Views from the Region The government has issued six economic packages in an effort to bolster the economy amid the slowdown, focusing on simplified business-permit processing, incentives for investors, and loan support for labor-intensive industries. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-vi-q4-2015) Vietnam - Views from the Region Exports also put in a strong performance, reaching US$120.7 billion (+9.6%). Given the strength of the economy, in September, the National Salary Council submitted a proposal to raise the minimum wage in 2016 by 12.4%. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ph-q4-2015) Philippines - Views from the Region The economy improved in Q2 2015, with GDP growth of 5.6% compared with (a revised) 5% in Q1 2015. Such growth was due to an increase in private construction, which grew 10.4% in Q1 2015, with infrastructure spending in catch-up mode in Q2 2015. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-th-q4-2015) Thailand - Views from the Region The Thai military government will remain in power until at least 2017 as the promised elections have been postponed. This follows the junta's decision to rewrite the first draft of its constitution before presenting it to the public for approval. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-ko-q4-2015) Korea - Views from the Region The OECD cut South Korea's economic growth outlook from its previous estimate of 3% in June to 2.7%. It also lowered the growth forecast for 2016 from 3.6% to 3.1%. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-my-q4-2015) Malaysia - Views from the Region The falling price of Malaysian oil exports, political uncertainty, and a general currency crisis in the region, stemming from volatile global financial conditions, has dampened growth prospects. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-sg-q4-2015) Singapore - Views from the Region Based on advanced estimates from the Ministry of Trade and Industry, the Singapore economy registered 1.4% GDP growth in Q3 2015 on a year-on-year basis, avoiding a technical recession. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-tw-q4-2015) Taiwan - Views from the Region The Taiwan Institute of Economic Research cut its forecast for GDP growth for 2015 to 0.83%, from 3.11% projected in July, as private consumption failed to benefit from energy cost savings and exports dropped due to the global economic slowdown. 07 November 2016 [](https://www.zuelligpharma.com/b/views-from-the-region/market-region-hk-q4-2015) Hong Kong - Views from the Region The city's economy grew 2.8% in Q2 2015, up from 2.4% in Q1 2015. The Hong Kong government is maintaining a forecast of 2%-3% for full-year GDP expansion. 07 November 2016 [](https://www.zuelligpharma.com/b/insights/a-spotlight-on-temperature-management) A Spotlight on Temperature Management The safety of a pharmaceutical product, effectiveness of a patient's treatment regimen or success of a clinical trial often relies upon how well we manage storage and transit temperature across the supply chain. 31 October 2016 [](https://www.zuelligpharma.com/b/news/esmya-launch-event-highlights) Esmya Launch Event Highlights A new first in class therapy for symptomatic uterine fibroids is now available in Singapore and Malaysia following the launch of Esmya by our Commercial Solutions teams. 26 October 2016 [](https://www.zuelligpharma.com/b/insights/prevention-versus-treatment-are-we-ready-to-make-a-change) Prevention versus Treatment, are we ready to make a change? In traditional Chinese Medicine, a doctor was paid a retainer to keep patients healthy. If a patient became sick, the doctor would not be paid until the patient's health returned to normal. 25 October 2016 "}